How better financing could help create new cancer drugs
MIT finance researchers say a diversified ‘megafund’ of securities could help the industry deliver new products to consumers.
Piece by piece
MIT biologist Schwartz relishes the challenge of picking apart the cell’s most complex structure.
Predicting how proteins will partner
Amy Keating models critical interactions that underlie most cellular functions.
Going with the flow
New 3-D microfluidic system offers greater control over production of drug-delivering nanoparticles.
Getting bacteria to do a plant’s job
Researchers engineer microbes for low-cost production of precursor of anticancer drug Taxol and other pharmaceuticals.
An easier way to synthesize new drug candidates
MIT chemists’ answer to long-standing problem could have a big impact on pharmaceutical business.
Why cancer drugs lose their power
MIT biologists show how tumors can become resistant to the commonly used chemotherapy drug cisplatin.
